Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Anticipating iSpecimens Quarterly Earnings Report Impact on Stock Prices

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Finance_Investment (2)
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

iSpecimen (NASDAQ: ISPC) is gearing up to unveil its latest quarterly earnings on March 13, 2024. Analysts are predicting an EPS of $-0.24 for this quarter, and investors are eagerly awaiting the results. The company’s performance in this quarter could set the tone for future growth and impact stock prices significantly.

Looking back at iSpecimen’s previous earnings, the company managed to exceed expectations in the last quarter by $0.12. However, this positive surprise led to a 3.23% drop in share price the next day. Here’s a snapshot of iSpecimen’s historical earnings performance and the resulting price changes:

– Q3 2023: EPS Estimate -0.35, EPS Actual -0.23, Price Change -3.0%
– Q2 2023: EPS Estimate -0.30, EPS Actual -0.39, Price Change 0.0%
– Q1 2023: EPS Estimate -0.32, EPS Actual -0.27, Price Change 0.0%
– Q4 2022: EPS Estimate -0.37, EPS Actual -0.24, Price Change -3.0%

As of March 11, iSpecimen’s shares were trading at $0.41, marking a significant 67.56% decrease over the past year. With this downward trend, long-term investors may be feeling apprehensive ahead of the upcoming earnings report.

To stay updated on iSpecimen’s earnings announcements, investors can check out the company’s earnings calendar on their website.

ISPC Stock Holds Steady with Flat Price Movement on March 12, 2024

On March 12, 2024, ISPC stock had a relatively uneventful day in terms of price movement. The stock opened at $0.41, which was $0.00 higher than its previous close. Throughout the trading day, the price of ISPC shares remained flat, resulting in a 0.00% change in value. Investors may interpret the lack of price movement as a sign of stability or indecision in the market. Overall, the performance of ISPC on March 12, 2024, suggests that the stock is holding steady but not experiencing any significant price gains or losses. Investors should continue to monitor market trends and company news to make informed decisions about their investments in ISPC.

ISPC Stock Performance Analysis: Mixed Results on March 12, 2024

On March 12, 2024, ISPC stock showed mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was $10.40 million, which decreased by 6.58% compared to the previous year. However, the total revenue for the third quarter of the year was $2.78 million, showing a significant increase of 70.92% since the previous quarter.

ISPC’s net income for the past year was -$10.24 million, a decrease of 14.33% compared to the previous year. On the other hand, the net income for the third quarter was -$2.11 million, showing a positive trend with an increase of 39.4% since the previous quarter.

In terms of earnings per share (EPS), ISPC reported a negative EPS of -$1.16 for the past year, which decreased by 12.9% compared to the previous year. However, the EPS for the third quarter was -$0.23, showing a positive increase of 39.6% since the previous quarter.

Overall, ISPC stock performances on March 12, 2024, reflected a mix of positive and negative trends in the company’s financial performance. Investors and analysts may need to closely monitor ISPC’s financial results in the coming quarters to assess the company’s overall performance and future potential.

Tags: ISPC
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Budgeting (1)

Investors Bullish on Celsius Holdings Options Trades and Price Range Analysis

Real Estate Investment Trading online

Analyst Perspectives on Kimco Realty A Diverse Outlook

Biotechnology Stock Market Today (1)

AnaptysBio Receives Upgrade from Wedbush Shares Surge

Recommended

Cardano Stock

Cardano at a Crossroads: Navigating Critical Support Levels Amid Major Developments

3 months ago
Tesla Stock

Tesla Stock: Musk’s $30B Payday Amid Customer Exodus

6 months ago
Oxford Lane Capital Stock

Oxford Lane Capital Implements Strategic Overhaul with Reverse Split and Buybacks

5 months ago
Ciena Stock

Ciena Shares Hit Record Peak Amid AI Infrastructure Surge

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Trending

DroneShield Stock
Analysis

DroneShield Shares Face Headwinds Despite Record Performance

by Jackson Burston
February 8, 2026
0

A significant disconnect has emerged for DroneShield Ltd. The counter-drone technology company posted explosive growth for fiscal...

Rock Tech Lithium Stock

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Puma Biotechnology Stock

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • DroneShield Shares Face Headwinds Despite Record Performance
  • Rock Tech Lithium: Investors Await the Final Go-Ahead
  • Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com